Llwytho...
Monitoring platelet function: what have we learned from randomized clinical trials?
Dual antiplatelet therapy, with aspirin plus a P2Y12 inhibitor agent, remains the cornerstone treatment after percutaneous coronary intervention. However, significant proportion of patients did experience recurrent ischemic events on aspirin plus clopidogrel and the concept of non-response to P2Y12...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cardiovasc Diagn Ther |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
AME Publishing Company
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6232346/ https://ncbi.nlm.nih.gov/pubmed/30498686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt.2018.10.10 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|